Cargando…
Mast cell activation disease: a concise practical guide for diagnostic workup and therapeutic options
Mast cell activation disease comprises disorders characterized by accumulation of genetically altered mast cells and/or abnormal release of these cells' mediators, affecting functions in potentially every organ system, often without causing abnormalities in routine laboratory or radiologic test...
Autores principales: | Molderings, Gerhard J, Brettner, Stefan, Homann, Jürgen, Afrin, Lawrence B |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3069946/ https://www.ncbi.nlm.nih.gov/pubmed/21418662 http://dx.doi.org/10.1186/1756-8722-4-10 |
Ejemplares similares
-
Pharmacological treatment options for mast cell activation disease
por: Molderings, Gerhard J., et al.
Publicado: (2016) -
Risk of solid cancer in patients with mast cell activation syndrome: Results from Germany and USA
por: Molderings, Gerhard J., et al.
Publicado: (2017) -
Determination of Plasma Heparin Level Improves Identification of Systemic Mast Cell Activation Disease
por: Vysniauskaite, Milda, et al.
Publicado: (2015) -
A survey of the currently known mast cell mediators with potential relevance for therapy of mast cell-induced symptoms
por: Molderings, Gerhard J., et al.
Publicado: (2023) -
Case Report: Treatment of systemic mastocytosis with sunitinib
por: Molderings, Gerhard J., et al.
Publicado: (2017)